Advertisement
Screener

EDESA BIOTECH, INC. (EDSA) Deferred State and Local Income Tax Expense (Benefit)

1.2 / 5 stars · 13/53 Roast Me

EDESA BIOTECH, INC. Deferred State and Local Income Tax Expense (Benefit)

EDESA BIOTECH, INC. (EDSA) reported Deferred State and Local Income Tax Expense (Benefit) of -$457.70 thousand for the 12-month period ending 2018-09-30, per its 10-K filed 2018-11-30.

Discontinued › Expense Statement › Income Tax

us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit · last filed 2018-11-30

  • EDESA BIOTECH, INC. deferred state and local income tax expense (benefit) for fiscal 2018 was -$457.70K.
  • EDESA BIOTECH, INC. deferred state and local income tax expense (benefit) for fiscal 2017 was -$468.30K.
  • EDESA BIOTECH, INC. deferred state and local income tax expense (benefit) for fiscal 2016 was -$399.00K.
  • EDESA BIOTECH, INC. deferred state and local income tax expense (benefit) for fiscal 2015 was -$328.70K.
Period endDeferred State and Local Income Tax Expense (Benefit) 1 monthDeferred State and Local Income Tax Expense (Benefit) 12 month
2018-09-30-$457.70K
10-K · filed 2018-11-30
2017-09-30-$468.30K
10-K · filed 2018-11-30
2016-09-30-$399.00K
10-K · filed 2017-12-01
2015-09-30-$328.70K
10-K · filed 2017-12-01
2014-09-30-$32.50K
10-K · filed 2016-12-14
2014-08-31-$458.00K
10-K · filed 2016-12-14
2013-08-31-$251.90K
10-K · filed 2015-12-14
2012-08-31-$412.70K
10-K · filed 2014-11-21

Similar stocks

Stock NameCountryMarket CapPE Ratio
CervoMed Inc. (CRVO)United States$0.038B-1.39
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98
Celularity Inc (CELU)United States$0.038B-0.34
Actinium Pharmaceuticals, Inc. (ATNM)United States$0.038B2.73
FILANA THERAPEUTICS, INC. (FLNA)United States$0.038B-1.05
PMGC Holdings Inc. (ELAB)United States$0.037B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
BriaCell Therapeutics Corp. (BCTX)$0.037B
Seres Therapeutics, Inc. (MCRB)United States$0.036B-3.45
Kairos Pharma, LTD. (KAPA)United States$0.041B